Literature DB >> 10228044

Impaired T cell proliferation in acute dengue infection.

A Mathew1, I Kurane, S Green, D W Vaughn, S Kalayanarooj, S Suntayakorn, F A Ennis, A L Rothman.   

Abstract

Decreased proliferative responses to mitogens and recall Ags have been observed in PBMC obtained during several acute human viral infections. To determine whether cell-mediated responses are altered during acute dengue infection, we examined the proliferative responses of PBMC from children enrolled in a prospective study of dengue infections in Thailand. All responses of PBMC during acute illness were compared with the same patients' PBMC obtained at least 6 mo after their infection. Proliferative responses to PHA, anti-CD3, tetanus toxoid, and dengue Ags were decreased significantly in PBMC obtained during the acute infection. The proliferative responses to PHA were restored by the addition of gamma-irradiated autologous convalescent or allogeneic PBMC. Cell contact with the irradiated PBMC was necessary to restore proliferation. Non-T cells from the acute PBMC of dengue patients did not support proliferation of T cells from control donors in response to PHA, but T cells from the PBMC of patients with acute dengue proliferated if accessory cells from a control donor were present. Addition of anti-CD28 Abs restored anti-CD3-induced proliferation of the PBMC of some patients. The percentage of monocytes was reduced in the acute sample of PBMC of the dengue patients. Addition of IL-2 or IL-7, but not IL-4 or IL-12, also restored proliferation of acute PBMC stimulated with anti-CD3. The results demonstrate that both quantitative and qualitative defects in the accessory cell population during acute dengue illness result in a depression of in vitro T cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228044

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.

Authors:  E L Azeredo; L M De Oliveira-Pinto; S M Zagne; D I S Cerqueira; R M R Nogueira; C F Kubelka
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.

Authors:  A C McNeil; W L Shupert; C A Iyasere; C W Hallahan; J A Mican; R T Davey; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.

Authors:  Sonja M Best; Keely L Morris; Jeffrey G Shannon; Shelly J Robertson; Dana N Mitzel; Gregory S Park; Elena Boer; James B Wolfinbarger; Marshall E Bloom
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.

Authors:  Iulia Popescu; Matthew R Pipeling; Pali D Shah; Jonathan B Orens; John F McDyer
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

5.  Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load.

Authors:  John C Tilton; Marlise R Luskin; Alison J Johnson; Maura Manion; Claire W Hallahan; Julia A Metcalf; Mary McLaughlin; Richard T Davey; Mark Connors
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.

Authors:  Christiana Iyasere; John C Tilton; Alison J Johnson; Souheil Younes; Bader Yassine-Diab; Rafick-Pierre Sekaly; William W Kwok; Stephen A Migueles; Alisha C Laborico; W Lesley Shupert; Claire W Hallahan; Richard T Davey; Mark Dybul; Susan Vogel; Julia Metcalf; Mark Connors
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 7.  Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern.

Authors:  Mattia Trunfio; Alessia Savoldi; Ottavia Viganò; Antonella d'Arminio Monforte
Journal:  Infection       Date:  2016-07-22       Impact factor: 3.553

8.  HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.

Authors:  Iulia Popescu; M Bradley Drummond; Lucio Gama; Allison Lambert; Aki Hoji; Tiffany Coon; Christian A Merlo; Robert A Wise; Jeanne Keruly; Janice E Clements; Gregory D Kirk; John F McDyer
Journal:  J Infect Dis       Date:  2016-09-09       Impact factor: 5.226

Review 9.  Dengue viral infections.

Authors:  G N Malavige; S Fernando; D J Fernando; S L Seneviratne
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

10.  Immunomodulatory effects of domoic acid differ between in vivo and in vitro exposure in mice.

Authors:  Milton Levin; Heather Leibrecht; James Ryan; Frances Van Dolah; Sylvain De Guise
Journal:  Mar Drugs       Date:  2008-12-22       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.